University of Alabama at Birmingham
Pediatric Hematology-Oncology fellowship · Birmingham, AL · Program website
Other fellowships: Neonatal-Perinatal Medicine · Pediatric Cardiology · Pediatric Critical Care Medicine · Pediatric Emergency Medicine · Pediatric Gastroenterology · Pediatric Infectious Diseases · Pediatric Pulmonology · Pediatric Endocrinology · Pediatric Nephrology
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Alabama at Birmingham's research in pediatric hematology-oncology, which the program shares with other departments and affiliated hospitals.
Pediatric Hematology-Oncology at University of Alabama at Birminghamshared by every program there, not this program's own
Institution-level: all pediatric hematology-oncology publications from University of Alabama at Birmingham and affiliated institutions, since 2022. Updated 2026-11-07; refreshed daily.
Works per year · * 2026 so far
Pediatric Hematology-Oncology research topics at University of Alabama at Birmingham
Papers in the window; each links to the list on OpenAlex.
- Multiple Myeloma Research and Treatments 167
- Glioma Diagnosis and Treatment 164
- Cancer survivorship and care 148
- Cancer Immunotherapy and Biomarkers 122
- Acute Myeloid Leukemia Research 121
- Pancreatic and Hepatic Oncology Research 107
- Ovarian cancer diagnosis and treatment 92
- Histiocytic Disorders and Treatments 85
Most cited at University of Alabama at Birmingham since 2024
All pediatric hematology-oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in ChildrenSumit Gupta et al. · New England Journal of Medicine · 2024 · PubMed · cited 240
- Global, regional, and national burden of breast cancer among females, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Kayleigh Pavitra Bhangdia et al. · The Lancet Oncology · 2026 · PubMed · cited 174
- Acquired resistance in cancer: towards targeted therapeutic strategiesAlice Soragni et al. · Nature reviews. Cancer · 2025 · PubMed · cited 145
- Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneityAteeq Muhammed Khaliq et al. · Nature Genetics · 2024 · PubMed · cited 132
- Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic LeukemiaElias Jabbour et al. · JAMA · 2024 · PubMed · cited 131
- Safety and activity of talquetamab in patients with relapsed or refractory multiple myeloma (MonumenTAL-1): a multicentre, open-label, phase 1–2 studyAjai Chari et al. · The Lancet Haematology · 2025 · PubMed · cited 127
- Teclistamab plus Daratumumab in Relapsed or Refractory Multiple MyelomaLuciano J. Costa et al. · New England Journal of Medicine · 2025 · PubMed · cited 117
- Interruption of the intratumor CD8+ T cell:Treg crosstalk improves the efficacy of PD-1 immunotherapyShannon N Geels et al. · Cancer Cell · 2024 · PubMed · cited 116
- Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisitedJan‐Inge Henter et al. · Blood · 2024 · PubMed · cited 110
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
<a href="https://openprograms.org/programs/university-alabama-birmingham-peds-heme-onc"><img src="https://openprograms.org/programs/university-alabama-birmingham-peds-heme-onc/badge.svg" alt="University of Alabama at Birmingham Pediatric Hematology-Oncology fellowship on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.